William Farrar, MD, Professor of Surgery and director of Surgical Oncology and a national authority on breast cancer detection and treatment, has been named director of the
newly opened JamesCare Comprehensive Breast Center. Farrar will continue
to see patients and, as director, he will develop the new center's
clinical strategy. The JamesCare Comprehensive Breast Center is central Ohio's only comprehensive breast cancer center, and first in the Midwest to offer under one roof the full continuum of breast cancer care, from prevention and screening through detection, diagnosis, treatment and survivorship.
Randy Wexler, MD, Assistant Professor of Family Medicine, has received the Ohio State Medical Association's inaugural Physician Advocate Award. The honor recognizes a physician who goes beyond his or her primary clinical care role by advocating at the local, state or federal levels for the well-being of the medical profession, patients and communities in which he or she serves.
Larry Schlesinger, MD, Professor of Internal Medicine and director of the Division of Infectious Diseases, has been named a 2011 University Distinguished Scholar. The award recognizes exceptional scholarly accomplishments by senior professors who have compiled a substantial body of research.
Allison Macerollo, MD, Assistant Professor of Clinical Family Medicine, has been selected to receive a 2010-2011 Alumni Award for Distinguished Teaching. Macerollo is one of 11 who were chosen from approximately 1,000 nominations submitted by faculty and students.
Congratulations to Jennifer Dickerson, MD, Assistant Professor of Clinical Internal Medicine; Craig Hofmeister, MD, Assistant Professor of Internal Medicine; Matthew Old, MD, Assistant Professor of Otolaryngology; and Philip Payne, PhD, Chair of Biomedical Informatics. All were selected for "40 Under 40" Awards by Columbus Business First. This honor recognizes area leaders who have distinguished themselves by their professional and personal contributions to central Ohio. Their stories will appear in the May 27 edition of Business First.
Susan Havercamp, PhD, Associate Professor of Psychiatry, has been named a fellow in the American Association on Intellectual and Developmental Disabilities (AAIDD). Fellows are recognized for their leadership in the association and meritorious contributions to the field of intellectual and developmental disabilities.
Rene Anand, PhD, Professor of Pharmacology, has been appointed to the Scientific Advisory Board of Autism Speaks, which is dedicated to advancing autism prevention, treatment and ultimately its cure. Anand serves as the first chair of the steering committee for the newly established Marci and Bill Ingram Comprehensive Center for Autism Spectrum Disorders at Ohio State and Nationwide Children's Hospital.
Larry Schlesinger, MD, Professor of Internal Medicine and director of the Division of Infectious Diseases, has been elected to fellowship in the American Academy of Microbiology.
Leslie Wexner, Ohio State alumnus and Board of Trustees Chair announced a gift of $100 million to the University.
The $100 million commitment includes $65 million from Wexner and $35
million from Limited Brands Foundation. The majority of this generous
donation will be allocated to the Medical Center and the James Cancer
Hospital and Solove Research Institute, with additional gifts to the
Wexner Center for the Arts and other areas. Wexner, chairman and CEO of
The Limited Brands, is a 1959 Ohio State graduate.
Peter Mohler, PhD, a prominent medical researcher from the University of Iowa 's Carver College of
Medicine, has been named director of Ohio State 's Davis Heart and Lung Research Institute (DHLRI) .He will also be a professor of Internal Medicine. Mohler was named a Pew Scholar by the Pew Charitable Trusts in 2007 and a Kavli Scholar of the U.S. National Academy of Sciences in 2009. Mohler's research focuses on solving the pathways underlying potentially fatal human diseases including cardiac arrhythmia, diabetes and neurological dysfunction.
Martha Gulati, MD, Associate Professor of Clinical Internal Medicine and a nationally recognized expert in the study of women and heart disease , has been named director for Preventive Cardiology and Women's Cardiovascular Health at Ohio State. Gulati is a co-author of the most recent guidelines published by the American Heart Association for heart disease prevention in women. She has co-written two books, Heart Power Recipes (2004), and Saving Women's Hearts (2011). She is a principal investigator of the STILETTO Study (women with Cardiac Syndrome X) , a co-investigator on the Women's Ischemic Syndrome Evaluation (WISE) study and previously served as a co-investigator on the Women's Health Initiative (WHI).
Of the 558 local doctors included on the 2011-12 national Best Doctors in America list published by Best Doctors Inc., 483 (87 percent) are Ohio State faculty members, practicing at Medical Center hospitals, Nationwide Children's Hospital or other local facilities. The current list provides additional evidence of our growing expertise, as 65 more Ohio State-affiliated physicians were honored in 2011-12 than in the previous Best Doctors in America list.
The U.S. Department of Health and Human Services announced in late December that Ohio State will receive $100 million in federal funds to support Medical Center expansion. The funds will allow for the addition of radiation oncology and associated cancer services as an integral component of the new Arthur G. James Cancer Hospital and Richard J. Solove Research Institute slated to open in 2014. The funds, disbursed by the U.S. Department of Health and Human Services, were awarded through a competitive grant program created by the Patient Protection and Affordable Care Act of 2010.
The Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCCJames) has received the highest rating possible - "exceptional" - on its five-year Support Grant renewal application to the National Cancer Institute (NCt) and the highest ever inOhio State' s history. In addition, the NCI deemed that our cancer center "should serve as the model for other matrix university-based centers." The Support Grant serves as the OSUCCC-James' major funding source for scientific leadership and administration, shared technology and services, and development. Ohio State is one of only 40 NCl-designated comprehensive cancer centers, a designation that we have had since 1976.
Medical Center CEO Steven G. Gabbe, MD, was one of "12 People With Diabetes Who Are Helping Others" profiled in the November Diabetes Forecast, the national magazine of the American Diabetes Association. The magazine saluted Gabbe's contributions to others through his administrative and clinical
leadership while also acting as a role model "running marathons, eating healthfully, and practicing good diabetes self-care."
Robert M. Taylor, MD, Associate Professor of Clinical Neurology, has been named a fellow of the American Academy of Hospice and Palliative Medicine. Taylor received fellowship status by demonstrating significant commitment to scholarship in the field of hospice and palliative medicine. Taylor, who also is a medical ethicist, specializes in pain and symptom management in patients with life-limiting diseases.
Michael A. Caligiuri, MD, director of the OSU Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute, is one of four scientists nationwide this year - and the first-ever from Ohio State - to receive a prestigious MERIT Award from the National Cancer Institute. The award recognizes researchers who have demonstrated superior competence and outstanding productivity.
Carlo Croce, MD, Chair of the Department of Molecular Virology, Immunology and Medical Genetics, was inducted Oct. 9 as a member of the 2010 class of the American Academy of Arts and Sciences. One of the nation's oldest and most prestigious honorary societies, the academy undertakes studies of complex and emerging problems.
Richard Nelson, MD, professor and vice chair of clinical affairs in Emergency Medicine, was recently elected president-elect of the American Board of Emergency Medicine (ABEM). The ABEM establishes the credentialing requirements and examinations to evaluate physicians who seek certification in Emergency Medicine. Nelson has served the ABEM in many positions since 1983 and has been a member of its board of directors since July 2004.
Ali Rezai, MD, Professor or Neurological Surgery has been elected president of the American Society for Stereotactic and Functional Neurosurgery (ASSFN). The main goals of ASSFN are to improve patient care, support clinical research and offer leadership in undergraduate and graduate education. Rezai specializes in severe movement disorders, psychiatric conditions, chronic pain and brain injuries.
Catherine Lucey, MD, Professor of Clinical Internal Medicine, has been appointed Interim Dean of the College of Medicine, as Wiley W. "Chip" Souba, MD, ScD, has taken the position of Dean of Dartmouth Medical School and Vice President for Health Affairs. Dr. Lucey will continue to serve as the Vice Dean for Education.
Daniel Sedmak, MD, has been appointed Chair of the Department of Pathology. Dr. Sedmak previously served as chair from 1997-2003 and has been Interim Chair of Pathology for the past year. He is also the director of the Office of Global Health Education and co-director of the Health Sciences Center for Global Health. Dr. Sedmak is a well respected NIH investigator who has published more than 110 peer-reviewed journal articles.
Philip Payne, PhD, has been appointed Chair of the Department of Biomedical Informatics. Dr. Payne joined the faculty in 2006. He is very active in Ohio State's Center for Clinical and Translational Science, serving as director of the Biomedical Informatics Program, as well as being co-investigator on the Clinical and Translational Science Award and on the National Cancer Institute SPORE grant.
Jonathan Groner, MD, Professor of Clinical Surgery, will serve as the Interim Director of the Division of Pediatric Surgery. Dr. Groner joined the faculty in 1999. He also serves as the medical director of Nationwide Children's Hospital Level 1 Trauma Program.
John Byrd, MD, Professor of Internal Medicine, received the inaugural Richard L. Schilsky Cancer and Leukemia Group B (CALGB) Achievement Award. CALGB is a nationwide clinical research community sponsored by the National Cancer Institute. Dr. Byrd was recognized for his research accomplishments with several therapeutic agents active in chronic lymphocytic leukemia and related leukemia and lymphoma.
Howard Werman, MD, Associate Professor of Clinical Emergency Medicine and medical director of MedFlight, has been named Medical Director of the Year by the Air Medical Physician Association. Dr. Werman is recognized for his contributions to MedFlight, the well-being of the flight crew members and the success of the transport program.
Have you or a colleague recently been honored? Tell us about it! Email Heather.
